Literature DB >> 15657506

Localization of parathyroid adenomas using 11C-methionine positron emission tomography.

Andrew D Beggs1, Sharon F Hain.   

Abstract

BACKGROUND AND AIM: In symptomatic hyperparathyroidism, pre-surgical localization of the suspected site of adenoma is desirable. All widely available techniques may have difficulty in localizing the site. The aim of this study was to determine whether 11C-methionine positron emission tomography (PET) could accurately localize parathyroid adenomas in patients in whom conventional imaging had failed. PATIENTS AND METHODS: Fifty-one patients presenting with hyperparathyroidism, and in whom other imaging techniques had failed to definitely identify the site of adenoma, were reviewed retrospectively after 11C-methionine PET scanning. Patients were followed up by surgical histology, or clinically if surgery was not performed.
RESULTS: 11C-Methionine PET scanning was found to have a sensitivity of 83%, a specificity of 100% and an accuracy of 88% in successfully locating parathyroid adenomas. Most false negatives were due to adenomas in the lower mediastinum that was outside the area of scanning.
CONCLUSIONS: 11C-Methionine PET is a reliable and highly accurate technique for localizing parathyroid adenomas in patients in whom conventional imaging techniques have failed. It is necessary to image to the level of the lower mediastinum.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15657506     DOI: 10.1097/00006231-200502000-00009

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  14 in total

1.  11C-methionine PET/CT in 99mTc-sestamibi-negative hyperparathyroidism in patients with renal failure on chronic haemodialysis.

Authors:  Domenico Rubello; Stefano Fanti; Cristina Nanni; Mohsen Farsad; Paolo Castellucci; Stefano Boschi; Roberto Franchi; Giuliano Mariani; Lorraine M Fig; Milton D Gross
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-01-25       Impact factor: 9.236

2.  Clinical value and limitations of [11C]-methionine PET for detection and localization of suspected parathyroid adenomas.

Authors:  Ken Herrmann; Toshiki Takei; Kakuko Kanegae; Tohru Shiga; Andreas K Buck; Jennifer Altomonte; Markus Schwaiger; Tibor Schuster; Kenichi Nishijima; Yuji Kuge; Nagara Tamaki
Journal:  Mol Imaging Biol       Date:  2009-04-02       Impact factor: 3.488

Review 3.  Imaging for primary hyperparathyroidism--an evidence-based analysis.

Authors:  Radu Mihai; Dietmar Simon; Per Hellman
Journal:  Langenbecks Arch Surg       Date:  2009-07-10       Impact factor: 3.445

4.  Diagnostic performance of positron emission tomography using ¹¹C-methionine in patients with suspected parathyroid adenoma: a meta-analysis.

Authors:  Carmelo Caldarella; Giorgio Treglia; Maria Antonietta Isgrò; Alessandro Giordano
Journal:  Endocrine       Date:  2012-07-18       Impact factor: 3.633

5.  Detection and Characterization of Parathyroid Adenoma/Hyperplasia for Preoperative Localization: Comparison Between (11)C-Methionine PET/CT and (99m)Tc-Sestamibi Scintigraphy.

Authors:  In Kook Chun; Gi Jeong Cheon; Jin Chul Paeng; Keon Wook Kang; June-Key Chung; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2013-07-06

6.  Clinical value of ¹¹C-methionine PET/CT in patients with plasma cell malignancy: comparison with ¹⁸F-FDG PET/CT.

Authors:  Yuji Nakamoto; Kensuke Kurihara; Masatoshi Nishizawa; Kouhei Yamashita; Koya Nakatani; Tadakazu Kondo; Akifumi Takaori-Kondo; Kaori Togashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-23       Impact factor: 9.236

Review 7.  Endocrine tumors: the evolving role of positron emission tomography in diagnosis and management.

Authors:  M Naji; M Hodolic; S El-Refai; S Khan; M C Marzola; D Rubello; A Al-Nahhas
Journal:  J Endocrinol Invest       Date:  2009-10-09       Impact factor: 4.256

8.  Mediastinal Cystic Parathyroid Adenoma Diagnosed by Somatostatin Receptor Scintigraphy.

Authors:  Kenichi Yokota; Isao Kurihara; Yohji Matsusaka; Katsura Emoto; Tomoyuki Hishida; Takuma Oshida; Sakiko Kobayashi; Ayano Murai-Takeda; Kazutoshi Miyashita; Kohei Matsuda; Takahiro Nakagomi; Kosuke Matsuda; Hiroshi Itoh
Journal:  Intern Med       Date:  2020-12-07       Impact factor: 1.271

9.  Primary hyperparathyroidism: imaging to pathology.

Authors:  Sara Piciucchi; Domenico Barone; Giampaolo Gavelli; Alessandra Dubini; Devil Oboldi; Federica Matteuci
Journal:  J Clin Imaging Sci       Date:  2012-10-06

10.  Scintigraphic techniques in primary hyperparathyroidism: from pre-operative localisation to intra-operative imaging.

Authors:  Domenico Rubello; Milton D Gross; Giuliano Mariani; Adil AL-Nahhas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-03-10       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.